Indeed, Kwong et al. reported the strong effectiveness of PD‐1 blockade in relapsed or refractory cases of natural killer (NK)/T‐cell lymphoma18 with confirmed tumor cell expression of neoplastic PD‐L1 (nPD‐L1). This evidence concerns the gene CD274 and neoplasm.